Rosuvastatin
Links shared publicly online about this topic
Atorvastatin beats rosuvastatin for kidneys
theheart.org — “Two related trials suggest that the two statins have different effects on urinary protein excretion, with atorvastatin seemingly protective, and rosuvastatin exerting no protective effects, and potentially causing harm. Data on hard events, however, are still needed.” View full resource at theheart.org
Most Recently Shared on July 5, 2010 at 8:12 pm By:
PLANET I and II: Atorvastatin beats rosuvastatin for protecting kidneys in diabetic and nondiabetic patients: Two ... http://bit.ly/c76qEC
Rosuvastatin safe, effective in adolescents
endocrinetoday.com — “Rosuvastatin successfully lowered LDL levels and demonstrated a favorable safety profile after one year among children aged 10 to 17 years who h” View full resource at endocrinetoday.com
Most Recently Shared on March 10, 2010 at 4:06 pm By:
Rosuvastatin safe, effective in adolescents http://ow.ly/1gAEz
Rosuvastatin in the prevention of venous thromboembolism
blogs.theheart.org — “A landmark megatrial cuts the rate of DVT and pulmonary embolism by more than 40%, without any increased risk of bleeding. The JUPITER Trial releases its landmark findings in DVT and PE prevention.” View full resource at blogs.theheart.org
Most Recently Shared on May 29, 2009 at 4:01 pm By:
Dr Walton-Shirley Internist, Cardiologist, Physician, and Doctor
Rosuvastatin in the Prevention of Venous Thromboembolism: What are the implication of the JUPITER trial's landma.. http://bit.ly/Xf49m
Family Medicine Article | rosuvastatin
mdlinx.com — “Effect of Central Obesity, Low High-Density Lipoprotein Cholesterol and C-Reactive Protein Polymorphisms on C-Reactive Protein Levels During Treatment With Rosuvastatin (10 mg Daily)” View full resource at mdlinx.com
Most Recently Shared on November 30, 2010 at 8:19 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Effect of Central Obesity, Low High-Density Lipoprotein Cholesterol and C-Reactive Protein Polymorp... http://bit.ly/gg3lZb #FamPractice
FDA approves wider rosuvastatin label
theheart.org — “UPDATED WITH COMMENTARY // The FDA decision was announced Monday. Eligible patients for statin therapy now include those who qualify based on age, elevated hs-CRP, and one additional cardiovascular risk factor, a label that one expert considers” View full resource at theheart.org
Most Recently Shared on February 9, 2010 at 2:03 am By:
FDA approves expanded rosuvastatin label: The FDA's decision was announced late Monday. For complete story visit t... http://bit.ly/bzysE4
Cardiology Medical News about Rosuvastatin
mdlinx.com — “Glucose-Regulated Protein and Platelet Deposition. Effect of Rosuvastatin” View full resource at mdlinx.com
Most Recently Shared on April 8, 2010 at 5:10 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Glucose-Regulated Protein and Platelet Deposition. Effect of Rosuvastatin: Arteriosclerosis, Thromb... http://bit.ly/9GCzot #cardio #mdlinx
FDA approves new indication for rosuvastatin
endocrinetoday.com — “The FDA has approved rosuvastatin for the prevention of stroke, myocardial infarction and arterial revascularization in a select population o” View full resource at endocrinetoday.com
Most Recently Shared on February 9, 2010 at 4:07 pm By:
FDA approves new indication for rosuvastatin http://ow.ly/15uRc
JUPITER, rosuvastatin, and the European Medicines Agency : The Lancet
thelancet.com — “JUPITER, rosuvastatin, and the European Medicines Agency. By - Paul M Ridker, Robert J Glynn” View full resource at thelancet.com
Most Recently Shared on May 21, 2010 at 2:02 pm By:
JUPITER, rosuvastatin, and @EMA_News http://bit.ly/c8Puie
ingentaconnect Lipitor [atorvastatin] and Crestor [rosuvastatin] will be more af...
ingentaconnect.com — “ingentaconnect Lipitor [atorvastatin] and Crestor [rosuvastatin] will be more af...” View full resource at ingentaconnect.com
Most Recently Shared on November 16, 2010 at 8:13 am By:
Lipitor [atorvastatin] and Crestor [rosuvastatin] will be more affordable to everyone on Universal American's Me... http://bit.ly/dfIE7m
Cardiology Medical News about Rosuvastatin and Fluvastatin
mdlinx.com — “STATIN-D Study: Comparison of the Influences of Rosuvastatin and Fluvastatin Treatment on the Levels of 25 Hydroxyvitamin D” View full resource at mdlinx.com
Most Recently Shared on April 2, 2010 at 8:26 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
STATIN-D Study: Comparison of the Influences of Rosuvastatin and Fluvastatin Treatment on the Level... http://bit.ly/bj6iU3 #cardio #mdlinx
Is rosuvastatin (Crestor) nephrotoxic? - UKidney.com
ukidney.com — “Welcome to UKidney Please browse our many educational tools for the study and practice of nephrology, hypertension, and kidney transplant” View full resource at ukidney.com
Most Recently Shared on January 25, 2011 at 3:47 am By:
RenalFellowNetwork Health Site and Nephrology
RT @UKidney: Is rosuvastatin (Crestor) nephrotoxic? http://t.co/sriIIYv
Rosuvastatin shows little effect against new atrial fibrillation in HF
theheart.org — “Rosuvastatin's effect was weak in a post hoc analysis of the randomized trial and reached significance only after much statistical adjustment, leaving researchers unenthused.” View full resource at theheart.org
Most Recently Shared on August 31, 2009 at 10:26 pm By:
heartwire: GISSI-HF trial finds marginal statin effect against new atrial fib http://bit.ly/4mW5sp #ESC09
US FDA Approves New Indication For CRESTOR® (Rosuvastatin Calcium)
medicalnewstoday.com — “AstraZeneca (NYSE: AZN) announced that the US Food and Drug Administration (FDA) has approved CRESTOR® (rosuvastatin calcium) to reduce the risk of stroke, myocardial infarction (heart attack)” View full resource at medicalnewstoday.com
Most Recently Shared on February 10, 2010 at 12:37 pm By:
US FDA Approves New Indication For CRESTOR® (rosuvastatin Calcium) AstraZeneca (NYSE: AZN) announced that the US Foo.. http://bit.ly/a4TRFd
Rosuvastatin fails to lower CV events and death in ESRD patients
theheart.org — “Finally—a group of people who do not seem to benefit from statins. In the AURORA trial, rosuvastatin did not ward off cardiovascular events in patients with end-stage renal disease on hemodialysis. Just why this is so remains a mystery, but investigators speculate it might be due to the high degree of arterial calcification.” View full resource at theheart.org
Most Recently Shared on March 31, 2009 at 2:34 pm By:
heartwire #acc09 Statins offer no cardiovascular protection for patients with end-stage renal di.. http://tinyurl.com/d6grs4
Rosuvastatin Fails to Best Atorvastatin in IVUS Study of Atherosclerosis Progression - Forbes
forbes.com — “AstraZeneca announced today that its lipid-lowering agent rosuvastatin (Crestor) was not superior to atorvastatin (Lipitor, Pfizer) in reducing the progression of atherosclerosis as assessed by IVUS. The company announced the top-line results of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: Effect of Rosuvastatin Versus AtorvastatiN), which is scheduled to be [...]” View full resource at forbes.com
Most Recently Shared on September 2, 2011 at 11:25 pm By:
Drugs and Devices OW OW Health
Rosuvastatin Fails to Best Atorvastatin in IVUS Study of Atherosclerosis Progression: AstraZeneca annou... http://t.co/c0y6V2E #drug
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Endocrine Today
The official Twitter for Endocrine Today, clinical news on diabetes and endocrine disorders.
-
Dr Walton-Shirley
Dr Melissa Walton-Shirley performs invasive cardiology, nuclear cardiology, and stress echocardiography in a private practice in Glasgow, KY.
Advertisement
